This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Mirobio Limited, Oxford University Innovation Ltd. Active years: 2022.
Company Filing History:
1 out of 1 
1 out of 483 
Years Active: 2022
Title: Christopher Douglas Paluch: Innovator in Antibody Technology
Introduction
Christopher Douglas Paluch is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target human B and T lymphocyte attenuator (BTLA). His work has implications for treating various inflammatory, autoimmune, and proliferative diseases.
Latest Patents
Paluch holds 1 patent related to BTLA antibodies. This invention encompasses antibodies or antigen-binding fragments that specifically bind to human BTLA. More importantly, it includes agonistic antibodies that modulate the activity of BTLA, offering potential therapeutic applications in managing inflammatory and autoimmune disorders.
Career Highlights
Throughout his career, Paluch has been associated with prominent organizations such as Oxford University Innovation Ltd and Mirobio Limited. His work in these institutions has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Paluch has worked alongside notable colleagues, including Simon Paul Davis and Richard John Cornall. Their combined expertise has contributed to the advancement of antibody technology and its applications in medicine.
Conclusion
Christopher Douglas Paluch is a distinguished inventor whose work in antibody technology holds promise for treating complex diseases. His innovative contributions continue to impact the field of biotechnology significantly.